Ap-SAL-NP exhibited specific cytotoxicity toward SaOS2 CD133+ cells and intravenous injections via the tail vein of tumor-bearing mice exhibited significant antitumor activity compared with salinomycin and a control compound [89]. The gene discussed is PROM1; the disease is neoplasm.